Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 11,743Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5KADMON PHARMS LLC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Pharmtech & Ingredients
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2035-04-09

BELUMOSUDIL MESYLATE

US Patent Number : 11311541

Drug Substance Claim :

Drug Product Claim :

Application Number : 214783

Patent Use Code : U-3369

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-04-09

Sanofi Company Banner

02

arrow
Pharmtech & Ingredients
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2033-10-07

BELUMOSUDIL MESYLATE

US Patent Number : 10696660

Drug Substance Claim :

Drug Product Claim :

Application Number : 214783

Patent Use Code : U-3246

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-10-07

Sanofi Company Banner

03

arrow
Pharmtech & Ingredients
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2033-10-07

BELUMOSUDIL MESYLATE

US Patent Number : 10183931

Drug Substance Claim :

Drug Product Claim :

Application Number : 214783

Patent Use Code : U-3246

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-10-07

Sanofi Company Banner

04

arrow
Pharmtech & Ingredients
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2033-10-07

BELUMOSUDIL MESYLATE

US Patent Number : 9815820

Drug Substance Claim :

Drug Product Claim :

Application Number : 214783

Patent Use Code : U-3247

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-10-07

Sanofi Company Banner

05

arrow
Pharmtech & Ingredients
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2029-10-30

BELUMOSUDIL MESYLATE

US Patent Number : 8357693

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 214783

Patent Use Code : U-3247

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-10-30

Sanofi Company Banner